Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #2320 on Enanta Pharmaceuticals Inc (ENTA)
vinmantoo
10/07/22 11:40 AM
#2321 RE: DewDiligence #2320
MRK—Lagevrio misses_primary_endpoint_in_large_Oxford_U_trial: